InvestorsHub Logo
Followers 14
Posts 603
Boards Moderated 0
Alias Born 12/27/2017

Re: Hugon post# 369985

Wednesday, 08/11/2021 5:18:19 PM

Wednesday, August 11, 2021 5:18:19 PM

Post# of 403545
1. The only thing that matters at this point is topline data. Literally nothing more. The longer the wait, the more concerning.

2. I don't see an EUA no matter who says what on this board. We've been over this, and a dosed-60 patient cohort straight to EUA would be ludicrous. IPIX has no manufacturing/distribution/sales etc to meet EUA requirements. (been over this as well)... people are screaming about the vaccines not 'being safe' (even on this board) yet they've been in literally hundreds of millions of humans... 60 dosed people with B? Are you f*king kidding me?

3. Note: IPIX is a PO box run by an accountant and his clinical trials assistant. NOT a swiss BioTech. Relief Therapeutics is run by business people with post-grad business degrees, PhD's etc. They're serious. They're getting things done and going places. Not a fair comparison. NNVC might be a more appropriate comparison I think?

4. Nothing this company has *ever* done in its history has been expedient (except dilution, and payment to The Accountant).

5. There will be no in-house P3 from IPIX without significant outside assistance (grants/partnerships/license etc). There's no current funding to do this and the existing finance agreement isn't large enough to support a P3, to my knowledge, unless the SP magically (and unprecedentedly) went to $5/s. (If it cost $6M to dose 60 people, imagine the cost for 350-500 humans?)

Please let this IPIX nightmare end.

Why do you guys waste your time on covid cases of children and variant mania etc etc etc. IPIX will need a Ph3 trial apart from Putin's little web. It's going to be about 15 months until that Ph3 completes. You should waste your time pleading for IPIX to 1) hire an IR firm 2) complete a partnership 3) stop diluting 4) advance their IBD trial into Phase 2 5) release the antiviral #conferencegate data 5) release the covid ph2 data 6) hire a real ceo etc


the stupid stock will go to $2.50 if CEO doesn't dilute along the way and they are as smart as RElIEF THERAPEUTICS OTC SWISS COMPANY THAT HAS CRUSHED IT DURING COVID !!!!!!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News